News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,951 Results
Type
Article (62604)
Company Profile (465)
Press Release (669881)
Multimedia
Podcasts (125)
Webinars (17)
Section
Business (195920)
Career Advice (3505)
Deals (35429)
Drug Delivery (126)
Drug Development (85294)
Employer Resources (179)
FDA (17480)
Job Trends (15531)
News (344333)
Policy (34934)
Tag
Academia (2929)
Academic (1)
Accelerated approval (11)
Adcomms (32)
Allergies (106)
Alliances (51666)
ALS (117)
Alzheimer's disease (1556)
Antibody-drug conjugate (ADC) (182)
Approvals (17433)
Artificial intelligence (359)
Autoimmune disease (36)
Automation (18)
Bankruptcy (358)
Best Places to Work (12229)
BIOSECURE Act (21)
Biosimilars (132)
Biotechnology (351)
Bladder cancer (100)
Brain cancer (40)
Breast cancer (385)
Cancer (3045)
Cardiovascular disease (243)
Career advice (2971)
Career pathing (34)
CAR-T (209)
CDC (39)
Cell therapy (568)
Cervical cancer (23)
Clinical research (69806)
Collaboration (1098)
Company closure (3)
Compensation (685)
Complete response letters (31)
COVID-19 (2822)
CRISPR (66)
C-suite (351)
Cystic fibrosis (120)
Data (3062)
Decentralized trials (2)
Denatured (42)
Depression (74)
Diabetes (375)
Diagnostics (6586)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (162)
Drug pricing (148)
Drug shortages (36)
Duchenne muscular dystrophy (132)
Earnings (76098)
Editorial (48)
Employer branding (23)
Employer resources (157)
Events (116762)
Executive appointments (889)
FDA (19184)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (996)
Gene editing (146)
Generative AI (34)
Gene therapy (435)
GLP-1 (912)
Government (4998)
Grass and pollen (6)
Guidances (180)
Healthcare (20086)
HIV (44)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (179)
Immuno-oncology (10)
Indications (40)
Infectious disease (3013)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (124)
Interviews (688)
IPO (16634)
IRA (53)
Job creations (3762)
Job search strategy (2416)
Kidney cancer (14)
Labor market (50)
Layoffs (543)
Leadership (26)
Legal (8016)
Liver cancer (85)
Longevity (12)
Lung cancer (428)
Lymphoma (215)
Machine learning (11)
Management (62)
Manufacturing (424)
MASH (99)
Medical device (13707)
Medtech (13711)
Mergers & acquisitions (19544)
Metabolic disorders (951)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (139)
Neuropsychiatric disorders (41)
Neuroscience (2297)
NextGen: Class of 2025 (7189)
Non-profit (4893)
Now hiring (42)
Obesity (490)
Opinion (288)
Ovarian cancer (103)
Pain (120)
Pancreatic cancer (122)
Parkinson's disease (198)
Partnered (23)
Patents (311)
Patient recruitment (169)
Peanut (55)
People (57687)
Pharmaceutical (92)
Pharmacy benefit managers (24)
Phase I (21725)
Phase II (30633)
Phase III (22974)
Pipeline (1682)
Policy (237)
Postmarket research (2795)
Preclinical (9454)
Press Release (69)
Prostate cancer (150)
Psychedelics (45)
Radiopharmaceuticals (278)
Rare diseases (521)
Real estate (6012)
Recruiting (73)
Regulatory (24613)
Reports (41)
Research institute (2602)
Resumes & cover letters (566)
Rett syndrome (10)
RNA editing (10)
RSV (55)
Schizophrenia (98)
Series A (169)
Series B (118)
Service/supplier (10)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (3739)
State (2)
Stomach cancer (17)
Supply chain (80)
Tariffs (63)
The Weekly (81)
Vaccines (887)
Venture capital (56)
Weight loss (323)
Women's health (46)
Worklife (20)
Date
Today (73)
Last 7 days (396)
Last 30 days (2016)
Last 365 days (32714)
2025 (17660)
2024 (36862)
2023 (41472)
2022 (52683)
2021 (57296)
2020 (55909)
2019 (49201)
2018 (37325)
2017 (34532)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27959)
2012 (29566)
2011 (29960)
2010 (28316)
Location
Africa (1024)
Alabama (65)
Alaska (7)
Arizona (217)
Arkansas (14)
Asia (43746)
Australia (7500)
California (7559)
Canada (2373)
China (712)
Colorado (327)
Connecticut (336)
Delaware (194)
Europe (99727)
Florida (1137)
Georgia (244)
Hawaii (1)
Idaho (62)
Illinois (703)
India (28)
Indiana (367)
Iowa (18)
Japan (232)
Kansas (109)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1045)
Massachusetts (5812)
Michigan (256)
Minnesota (456)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (26)
Nevada (81)
New Hampshire (71)
New Jersey (2141)
New Mexico (30)
New York (2137)
North Carolina (1193)
North Dakota (10)
Northern California (3280)
Ohio (243)
Oklahoma (16)
Oregon (37)
Pennsylvania (1637)
Puerto Rico (18)
Rhode Island (35)
South America (1355)
South Carolina (35)
South Dakota (1)
Southern California (2820)
Tennessee (120)
Texas (1140)
United States (28425)
Utah (220)
Virginia (199)
Washington D.C. (75)
Washington State (664)
West Virginia (4)
Wisconsin (72)
732,951 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Press Releases
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
June 26, 2025
·
2 min read
Press Releases
uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development
June 16, 2025
·
2 min read
Press Releases
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
May 28, 2025
·
8 min read
Press Releases
Regenerative Medicine Market Size to Hit USD 169.55 Billion by 2034
June 11, 2025
·
1 min read
Press Releases
Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
June 25, 2025
·
2 min read
Press Releases
AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN
May 27, 2025
·
3 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Press Releases
AccurEdit Therapeutics’ ART001 Becomes China’s First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
May 29, 2025
·
4 min read
Press Releases
Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
May 7, 2025
·
11 min read
1 of 73,296
Next
